Glaukos Corp. (NYSE:GKOS) shares jumped 17.61% to $213.38 in after-hours trading Wednesday after the eye-care company beat third-quarter earnings per share estimates by 570% and raised its sales guidance.
The company reported results for the quarter ended Sept. 30.
Earnings and Revenue Beat
Revenue came in at $211.03 million, topping the analyst estimate of $168.22 million by 25.4%.
Non-GAAP earnings per share were $0.47, compared with an expected loss of 10 cents. That is a 570% surprise.
Net sales rose 58% year over year to $133.5 million.
Gross margin was about 85%, up from 78% a year earlier. Non-GAAP gross margin was about 88%.
Guidance Raise Drives the Rally
The company lifted 2026 net sales guidance to $775 million to $785 million, up from $680 million to $700 million.
Chairman and CEO Thomas Burns credited "two transformational growth drivers in iDose TR and Epioxa."
Glaukos ended the quarter with $339.8 million in cash.
Trading Metrics, Technical Analysis
Glaukos has a market capitalization of $10.70 billion, a 52-week high of $191.62 and a 52-week low of $76.88.
The Relative Strength Index (RSI) of GKOS stands at 64.76.
The stock has gained roughly 135.35% over the past 12 months.
Price Action: On Wednesday, GKOS stock closed at $181.43, up 0.14%, according to Benzinga Pro data.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Jirapong Manustrong / Shutterstock – ejk
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
